Asset Details
Do you wish to reserve the book?
Design and Synthesis of New Boron-Based Benzoc1,2,5oxadiazoles and Benzoc1,2,5thiadiazoles as Potential Hypoxia Inhibitors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Design and Synthesis of New Boron-Based Benzoc1,2,5oxadiazoles and Benzoc1,2,5thiadiazoles as Potential Hypoxia Inhibitors
Do you wish to request the book?
Design and Synthesis of New Boron-Based Benzoc1,2,5oxadiazoles and Benzoc1,2,5thiadiazoles as Potential Hypoxia Inhibitors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Design and Synthesis of New Boron-Based Benzoc1,2,5oxadiazoles and Benzoc1,2,5thiadiazoles as Potential Hypoxia Inhibitors
2023
Overview
Benzo[c][1,2,5]oxadiazoles and benzo[c][1,2,5]thiadiazoles are recognized to possess potent pharmacological activities including anticancer potential. In continuation of our research endeavors in the development of boron-based heterocycles as potential therapeutic agents, herein we report the design and synthesis of new series of boron-based benzo[c][1,2,5]oxadiazoles and benzo[c][1,2,5]thiadiazoles as anticancer agents targeting tumor hypoxia. A series of seventeen compounds were synthesized in two steps in an efficient manner via substitution reactions followed by subsequent hydrolysis of aryltrifluoroboronate salts into corresponding boronic acid derivatives in the presence of silica. This is the first example to develop boron-based hypoxia agents. The synthesized hybrids were characterized by suitable spectroscopic techniques. The biological studies are currently underway.
